Azitra, Inc.
AZTRCIK 0001701478 · Pharmaceutical Preparations · NYSE
- Azitra Inc (until 2024-01-04)
Revenue (TTM)
$7.5K
−100.0% YoY
Q1 May 2026
Net Income (TTM)
−$12.65M
−22.2% YoY
Q1 May 2026
EPS Diluted (TTM)
−$2.65
+85.7% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-168,986.6%
Q1 May 2026
Net Margin
-168,654.7%
Q1 May 2026
Free Cash Flow (TTM)
−$9.9M
Q1 May 2026
Cash
$10.05M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
16.19M sh
Q1 May 2026